Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Cancer image

Precision medicine: the future of cancer treatment?

March 2, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Cancer, Celgene, Precision, melanoma, oncology, underwood

There are plenty of advances in oncology treatments to be excited about – from immunotherapy to cancer vaccines and monoclonal …
Feature
GSK image

GSK and Novartis swap assets

March 1, 2015 Research and Development, Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, akt, merger, oncology, vaccines

GlaxoSmithKline’s planned major assets swap with Novartis has completed today as was predicted last week. Both firms announced the overhaul …
News
Actavis image

Actavis and AZ see FDA approval for ‘superbug’ drug

February 27, 2015 Research and Development, Sales and Marketing Actavis, AstraZeneca, Avycaz, FDA, US, ceftazidime/avibactam

Actavis and AstraZeneca’s combo ‘superbug’ drug Avycaz has been shown the green light to treat patients with complicated intra-abdominal infections …
News
richard_pott_bayer

Bayer MaterialScience gets new chairman

February 27, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Werner Baumann, richard pott

Dr Richard Pott has been appointed to the supervisory board at Bayer MaterialScience as its new chairman. Pott replaces Werner …
Appointment
sir_philip_hampton_gsk_chairman

GlaxoSmithKline announces board changes early

February 26, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Tom de Swaan, christopher gent, sir philip hampton

GlaxoSmithKline has confirmed that Sir Christopher Gent will step down early as chairman of GSK in May to be succeeded …
Appointment
lisa-giles

GenMark Diagnostics performs board shuffle

February 26, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genmark diagnostics, lisa giles, michael kagnoff

US diagnostic systems provider GenMark Diagnostics has named two new board members whilst announcing a resignation.  Lisa Giles (pictured) who …
Appointment
AZ image

AstraZeneca enters autoimmune diseases pact with Orca

February 25, 2015 Research and Development, Sales and Marketing AstraZeneca, autoimmune, orca, orphan nuclear receptor gamma inhibitors, psoriasis, retinoic

AstraZeneca has signed a three-year research deal with the UK-based biotech firm Orca to develop treatments for autoimmune diseases. The …
News
Napp image

Napp launches biosimilar in UK

February 25, 2015 Research and Development, Sales and Marketing Hospira, Napp, Remicade, anti-TNF biologic, biosimilar, infliximab, remsima

Napp Pharmaceuticals has launched its own biosimilar version of an anti-TNF biologic in Europe paving the way for patient access …
News
jean-christophe_tellier_ucb_ceo

UCB’s new chief executive picked as EU rep for MISG

February 25, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jean-Christophe Tellier, MISG, UCB

UCB’s newly-appointed chief executive Jean-Christophe Tellier has been selected to join the Ministerial Industry Strategy Group (MISG). Elected to the …
Appointment
Shire image

Shire to buy Meritage Pharma

February 25, 2015 Research and Development, Sales and Marketing AbbVie, Meritage Pharma, Shire, eoe, gastrointestinal

Shire has purchased Meritage Pharma, a privately-held company specialising in gastrointestinal and skin diseases for $70 million. The acquisition means …
News

FDA in Novartis cancer drug U-turn

February 24, 2015 Research and Development, Sales and Marketing Cancer, FDA, Farydak, Novartis, Revlimid, Velcade, myeloma

The FDA has overturned an earlier advisory committee recommendation and decided to approve Novartis’ blood cancer drug Farydak. In November …
News
Isentress image

Merck puts HIV drug in shared patent pool

February 24, 2015 Research and Development, Sales and Marketing AbbVie, Gilead, HIV, Merck, Raltegravir, Roche, isentress

Merck is teaming up with the Medicines Patent Pool (MPP) to license its paediatric HIV treatment in developing countries. The …
News
QELFA device

Novel device could help fight kidney disease

February 24, 2015 Research and Development, Sales and Marketing Bio Nano Consulting, Pfizer, QELFA, Rapamune, device, ime, kidney

A novel device that combines nanotechnology and a pregnancy tester could help treat kidney disease, according to a report by …
News
BMS image

BMS in $1.5 billion immuno-oncology expansion

February 24, 2015 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Rigel, flexus, immuno-oncology

Bristol-Myers Squibb has confirmed two major deals to enhance the company’s standing in the immuno-oncology field. The first agreement sees …
News
ronnie_meninger

Algatech gets new chief executive and chief scientist

February 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Algatech, Ronnie Meninger, Sammy Boussiba

Israel-based biotech Algatech has confirmed the appointment of Ronnie Meninger as its chief executive, and Sammy Boussiba as chief scientist. Meninger (pictured) …
Appointment
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026